Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for iSpecimen (ISPC) over the last 5 years, with Q3 2025 value amounting to -$3521.0.

  • iSpecimen's Asset Writedowns and Impairment fell 38078.15% to -$3521.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $514017.0, marking a year-over-year increase of 9197.65%. This contributed to the annual value of $705724.0 for FY2024, which is 13135.53% up from last year.
  • As of Q3 2025, iSpecimen's Asset Writedowns and Impairment stood at -$3521.0, which was down 38078.15% from -$93463.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Asset Writedowns and Impairment ranged from a high of $499960.0 in Q4 2024 and a low of -$234277.0 during Q4 2022
  • For the 5-year period, iSpecimen's Asset Writedowns and Impairment averaged around $68025.0, with its median value being $61986.0 (2023).
  • As far as peak fluctuations go, iSpecimen's Asset Writedowns and Impairment surged by 133590.77% in 2022, and later plummeted by 151911.63% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Asset Writedowns and Impairment stood at $127218.0 in 2021, then crashed by 284.15% to -$234277.0 in 2022, then soared by 126.46% to $61986.0 in 2023, then skyrocketed by 706.57% to $499960.0 in 2024, then crashed by 100.7% to -$3521.0 in 2025.
  • Its last three reported values are -$3521.0 in Q3 2025, -$93463.0 for Q2 2025, and $111041.0 during Q1 2025.